| I work for a medical software company which evaluated Watson for use in our diagnostic product. It should be seen as a Good Thing that medical is a Serious Field where Non-Serious Ideas get run through the ringer and fail. And that's what happened with Watson. The word from our engineers was that Watson was designed to sell commercials, not be a useful tool in a problem space like differential diagnosis or drug reactions. I think this is good. Financial has the same reputation. You can't just use agile to bust out a minimum viable medical or financial product. You will be chewed up and spit out. And rightfully so. Because when it comes to our health, or our money and our investments, we don't have tolerance for failure. OK, my social network double posted my communication, annoying but it's just a communication. However "my financial tool just double posted a transaction", or "my prescriptions tool just doubled the dose of a medicine" -- these are not OK states at all. I wish Watson lived up to the hype, but sadly, our experience was that it does not. So it failing out of Healthcare isn't a surprise to us, nor is it a bad thing. |
This is the number one thing to remember about Watson. I've worked with teams within IBM that spent years and thousands upon thousands of man-hours trying to get it to be useful in a fairly well-defined, constrained use-case. Eventually they bailed and went to what was essentially a simple decision tree. It hits it out of the park on the sexy buzz-words, but I'm ready to curse the whole field for giving customers wildly inflated expectations.